- call +1-201-465-4211
- email sales@mrinsights.biz
Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their “bulk” counterparts primarily because of size.
There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.
Scope of the Report:
USA is a huge market, and the total sum of the industry is more than 8756.7 million USD in 2015. At the same time, this industry continuously increases, with the development of global economy.
USA is the largest market of nanopharmaceuticals, which occupies 60.69 percent of global nanopharmaceuticals market share in 2014. It is followed by Europe, which has around 33.37 percent of the global total industry. Other main regions which take important part in this industry include Japan and China.
The relatively-mature technology is NanoCrystalsTM, DissCubes® and Nanopure®. The carrier includes nanospheres, nanocapsules, solid lipid nanoparticles, microemulsion, nanoliposome, magnetic nanoparticles, polymeric micelles, dendrimers, and inorganic nanometer carrier.
The worldwide market for Nanopharmaceuticals is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Nanopharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Liposomes
Polymeric Micelles
Solid Lipid Nanoparticles
Microemulsion and Nnanoemulsion
Nanosuspension
Market Segment by Applications, can be divided into
Cancer and Tumor
Autoimmune Disorders
Inflammation
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nanopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nanopharmaceuticals, with price, sales, revenue and global market share of Nanopharmaceuticals in 2017 and 2018.
Chapter 3, the Nanopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nanopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Nanopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Nanopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Nanopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Liposomes
1.2.2 Polymeric Micelles
1.2.3 Solid Lipid Nanoparticles
1.2.4 Microemulsion and Nnanoemulsion
1.2.5 Nanosuspension
1.3 Market Analysis by Applications
1.3.1 Cancer and Tumor
1.3.2 Autoimmune Disorders
1.3.3 Inflammation
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 Nanopharmaceuticals Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Nanopharmaceuticals Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Nanopharmaceuticals Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Abbott
2.4.1 Business Overview
2.4.2 Nanopharmaceuticals Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbott Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 GlaxoSmithKline
2.5.1 Business Overview
2.5.2 Nanopharmaceuticals Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Roche
2.6.1 Business Overview
2.6.2 Nanopharmaceuticals Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sanofi
2.7.1 Business Overview
2.7.2 Nanopharmaceuticals Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Eli Lilly
2.8.1 Business Overview
2.8.2 Nanopharmaceuticals Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eli Lilly Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Astrazeneca
2.9.1 Business Overview
2.9.2 Nanopharmaceuticals Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Astrazeneca Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Johnson & Johnson
2.10.1 Business Overview
2.10.2 Nanopharmaceuticals Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Johnson & Johnson Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Celgene
2.11.1 Business Overview
2.11.2 Nanopharmaceuticals Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Celgene Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Novavax
2.12.1 Business Overview
2.12.2 Nanopharmaceuticals Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Novavax Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Stryker
2.13.1 Business Overview
2.13.2 Nanopharmaceuticals Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Stryker Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Gilead Sciences
2.14.1 Business Overview
2.14.2 Nanopharmaceuticals Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Gilead Sciences Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 OSI Pharmaceuticals
2.15.1 Business Overview
2.15.2 Nanopharmaceuticals Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 OSI Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Kadmon Pharmaceuticals
2.16.1 Business Overview
2.16.2 Nanopharmaceuticals Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.17 Samyang Biopharm
2.17.1 Business Overview
2.17.2 Nanopharmaceuticals Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Samyang Biopharm Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.18 Mitsubishi Pharma
2.18.1 Business Overview
2.18.2 Nanopharmaceuticals Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Mitsubishi Pharma Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.19 Kaken Pharmaceutical
2.19.1 Business Overview
2.19.2 Nanopharmaceuticals Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Kaken Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.20 Selecta Biosciences
2.20.1 Business Overview
2.20.2 Nanopharmaceuticals Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Selecta Biosciences Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.21 Par Pharmaceutical
2.21.1 Business Overview
2.2.2 Nanopharmaceuticals Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Par Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.22 Cerulean Pharma
2.22.1 Business Overview
2.22.2 Nanopharmaceuticals Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Cerulean Pharma Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.23 Navidea Biopharmaceuticals
2.23.1 Business Overview
2.23.2 Nanopharmaceuticals Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.24 Lummy
2.24.1 Business Overview
2.24.2 Nanopharmaceuticals Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Lummy Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Nanopharmaceuticals Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Nanopharmaceuticals Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Nanopharmaceuticals Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Nanopharmaceuticals Manufacturer Market Share in 2018
3.3.2 Top 6 Nanopharmaceuticals Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Nanopharmaceuticals Market Analysis by Regions
4.1 Global Nanopharmaceuticals Sales, Revenue and Market Share by Regions
4.1.1 Global Nanopharmaceuticals Sales and Market Share by Regions (2014-2019)
4.1.2 Global Nanopharmaceuticals Revenue and Market Share by Regions (2014-2019)
4.2 North America Nanopharmaceuticals Sales and Growth Rate (2014-2019)
4.3 Europe Nanopharmaceuticals Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Nanopharmaceuticals Sales and Growth Rate (2014-2019)
4.5 South America Nanopharmaceuticals Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Nanopharmaceuticals Sales and Growth Rate (2014-2019)
5 North America Nanopharmaceuticals by Country
5.1 North America Nanopharmaceuticals Sales, Revenue and Market Share by Country
5.1.1 North America Nanopharmaceuticals Sales and Market Share by Country (2014-2019)
5.1.2 North America Nanopharmaceuticals Revenue and Market Share by Country (2014-2019)
5.2 United States Nanopharmaceuticals Sales and Growth Rate (2014-2019)
5.3 Canada Nanopharmaceuticals Sales and Growth Rate (2014-2019)
5.4 Mexico Nanopharmaceuticals Sales and Growth Rate (2014-2019)
6 Europe Nanopharmaceuticals by Country
6.1 Europe Nanopharmaceuticals Sales, Revenue and Market Share by Country
6.1.1 Europe Nanopharmaceuticals Sales and Market Share by Country (2014-2019)
6.1.2 Europe Nanopharmaceuticals Revenue and Market Share by Country (2014-2019)
6.2 Germany Nanopharmaceuticals Sales and Growth Rate (2014-2019)
6.3 UK Nanopharmaceuticals Sales and Growth Rate (2014-2019)
6.4 France Nanopharmaceuticals Sales and Growth Rate (2014-2019)
6.5 Russia Nanopharmaceuticals Sales and Growth Rate (2014-2019)
6.6 Italy Nanopharmaceuticals Sales and Growth Rate (2014-2019)
7 Asia-Pacific Nanopharmaceuticals by Country
7.1 Asia-Pacific Nanopharmaceuticals Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Nanopharmaceuticals Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Nanopharmaceuticals Revenue and Market Share by Country (2014-2019)
7.2 China Nanopharmaceuticals Sales and Growth Rate (2014-2019)
7.3 Japan Nanopharmaceuticals Sales and Growth Rate (2014-2019)
7.4 Korea Nanopharmaceuticals Sales and Growth Rate (2014-2019)
7.5 India Nanopharmaceuticals Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Nanopharmaceuticals Sales and Growth Rate (2014-2019)
8 South America Nanopharmaceuticals by Country
8.1 South America Nanopharmaceuticals Sales, Revenue and Market Share by Country
8.1.1 South America Nanopharmaceuticals Sales and Market Share by Country (2014-2019)
8.1.2 South America Nanopharmaceuticals Revenue and Market Share by Country (2014-2019)
8.2 Brazil Nanopharmaceuticals Sales and Growth Rate (2014-2019)
8.3 Argentina Nanopharmaceuticals Sales and Growth Rate (2014-2019)
8.4 Colombia Nanopharmaceuticals Sales and Growth Rate (2014-2019)
9 Middle East and Africa Nanopharmaceuticals by Countries
9.1 Middle East and Africa Nanopharmaceuticals Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Nanopharmaceuticals Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Nanopharmaceuticals Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Nanopharmaceuticals Sales and Growth Rate (2014-2019)
9.3 Turkey Nanopharmaceuticals Sales and Growth Rate (2014-2019)
9.4 Egypt Nanopharmaceuticals Sales and Growth Rate (2014-2019)
9.5 Nigeria Nanopharmaceuticals Sales and Growth Rate (2014-2019)
9.6 South Africa Nanopharmaceuticals Sales and Growth Rate (2014-2019)
10 Global Nanopharmaceuticals Market Segment by Type
10.1 Global Nanopharmaceuticals Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Nanopharmaceuticals Sales and Market Share by Type (2014-2019)
10.1.2 Global Nanopharmaceuticals Revenue and Market Share by Type (2014-2019)
10.2 Liposomes Sales Growth and Price
10.2.1 Global Liposomes Sales Growth (2014-2019)
10.2.2 Global Liposomes Price (2014-2019)
10.3 Polymeric Micelles Sales Growth and Price
10.3.1 Global Polymeric Micelles Sales Growth (2014-2019)
10.3.2 Global Polymeric Micelles Price (2014-2019)
10.4 Solid Lipid Nanoparticles Sales Growth and Price
10.4.1 Global Solid Lipid Nanoparticles Sales Growth (2014-2019)
10.4.2 Global Solid Lipid Nanoparticles Price (2014-2019)
10.5 Microemulsion and Nnanoemulsion Sales Growth and Price
10.5.1 Global Microemulsion and Nnanoemulsion Sales Growth (2014-2019)
10.5.2 Global Microemulsion and Nnanoemulsion Price (2014-2019)
10.6 Nanosuspension Sales Growth and Price
10.6.1 Global Nanosuspension Sales Growth (2014-2019)
10.6.2 Global Nanosuspension Price (2014-2019)
11 Global Nanopharmaceuticals Market Segment by Application
11.1 Global Nanopharmaceuticals Sales Market Share by Application (2014-2019)
11.2 Cancer and Tumor Sales Growth (2014-2019)
11.3 Autoimmune Disorders Sales Growth (2014-2019)
11.4 Inflammation Sales Growth (2014-2019)
11.5 Others Sales Growth (2014-2019)
12 Nanopharmaceuticals Market Forecast (2019-2024)
12.1 Global Nanopharmaceuticals Sales, Revenue and Growth Rate (2019-2024)
12.2 Nanopharmaceuticals Market Forecast by Regions (2019-2024)
12.2.1 North America Nanopharmaceuticals Market Forecast (2019-2024)
12.2.2 Europe Nanopharmaceuticals Market Forecast (2019-2024)
12.2.3 Asia-Pacific Nanopharmaceuticals Market Forecast (2019-2024)
12.2.4 South America Nanopharmaceuticals Market Forecast (2019-2024)
12.2.5 Middle East and Africa Nanopharmaceuticals Market Forecast (2019-2024)
12.3 Nanopharmaceuticals Market Forecast by Type (2019-2024)
12.3.1 Global Nanopharmaceuticals Sales Forecast by Type (2019-2024)
12.3.2 Global Nanopharmaceuticals Market Share Forecast by Type (2019-2024)
12.4 Nanopharmaceuticals Market Forecast by Application (2019-2024)
12.4.1 Global Nanopharmaceuticals Sales Forecast by Application (2019-2024)
12.4.2 Global Nanopharmaceuticals Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Nanopharmaceuticals Picture
Table Product Specifications of Nanopharmaceuticals
Figure Global Sales Market Share of Nanopharmaceuticals by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
